207 related articles for article (PubMed ID: 15548915)
21. Spasmodic dysphonia: botulinum toxin injection after recurrent nerve surgery.
Ludlow CL; Naunton RF; Fujita M; Sedory SE
Otolaryngol Head Neck Surg; 1990 Feb; 102(2):122-31. PubMed ID: 2113236
[TBL] [Abstract][Full Text] [Related]
22. Botulinum toxin therapy of laryngeal muscle hyperactivity syndromes: comparing different botulinum toxin preparations.
Truong DD; Bhidayasiri R
Eur J Neurol; 2006 Feb; 13 Suppl 1():36-41. PubMed ID: 16417596
[TBL] [Abstract][Full Text] [Related]
23. Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin.
Brin MF; Blitzer A; Stewart C
Adv Neurol; 1998; 78():237-52. PubMed ID: 9750921
[No Abstract] [Full Text] [Related]
24. Laryngeal electromyography in movement disorders: preliminary data.
Kimaid PA; Quagliato EM; Crespo AN; Wolf A; Viana MA; Resende LA
Arq Neuropsiquiatr; 2004 Sep; 62(3A):741-4. PubMed ID: 15334243
[TBL] [Abstract][Full Text] [Related]
25. [Indications for botulinum toxin in laryngectomy].
Klap P; Marion MH; Perrin A; Fresnel-Elbaz E; Cohen M
Rev Laryngol Otol Rhinol (Bord); 1993; 114(4):281-7. PubMed ID: 8029549
[TBL] [Abstract][Full Text] [Related]
26. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients.
Blitzer A; Brin MF; Stewart CF
Laryngoscope; 1998 Oct; 108(10):1435-41. PubMed ID: 9778279
[TBL] [Abstract][Full Text] [Related]
27. Long-term therapy for spasmodic dysphonia: acoustic and aerodynamic outcomes.
Mehta RP; Goldman SN; Orloff LA
Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):393-9. PubMed ID: 11296047
[TBL] [Abstract][Full Text] [Related]
28. Use of Botulinum Toxin in Spasmodic Dysphonia: A Review of Recent Studies.
Khan HA
Cureus; 2023 Jan; 15(1):e33486. PubMed ID: 36628391
[TBL] [Abstract][Full Text] [Related]
29. Histology of nerves and muscles in adductor spasmodic dysphonia.
Chhetri DK; Blumin JH; Vinters HV; Berke GS
Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):334-41. PubMed ID: 12731628
[TBL] [Abstract][Full Text] [Related]
30. Treatment of the interarytenoid muscle with botulinum toxin for laryngeal dystonia.
Hillel AD; Maronian NC; Waugh PF; Robinson L; Klotz DA
Ann Otol Rhinol Laryngol; 2004 May; 113(5):341-8. PubMed ID: 15174759
[TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin injections for the treatment of spasmodic dysphonia.
Watts CC; Whurr R; Nye C
Cochrane Database Syst Rev; 2004; 2004(3):CD004327. PubMed ID: 15266530
[TBL] [Abstract][Full Text] [Related]
32. Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section.
Sulica L; Blitzer A; Brin MF; Stewart CF
Ann Otol Rhinol Laryngol; 2003 Jun; 112(6):499-505. PubMed ID: 12834116
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of botulinum toxin treatment for patients with spasmodic dysphonia.
Benninger MS; Gardner G; Grywalski C
Arch Otolaryngol Head Neck Surg; 2001 Sep; 127(9):1083-5. PubMed ID: 11556856
[TBL] [Abstract][Full Text] [Related]
34. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
Troung DD; Rontal M; Rolnick M; Aronson AE; Mistura K
Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
[TBL] [Abstract][Full Text] [Related]
35. The impact of long-term botulinum toxin injections on symptom severity in patients with spasmodic dysphonia.
Damrose JF; Goldman SN; Groessl EJ; Orloff LA
J Voice; 2004 Sep; 18(3):415-22. PubMed ID: 15331116
[TBL] [Abstract][Full Text] [Related]
36. Evidence for the effectiveness of botulinum toxin for spasmodic dysphonia from high-quality research designs.
Watts CR; Truong DD; Nye C
J Neural Transm (Vienna); 2008; 115(4):625-30. PubMed ID: 17564757
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia.
Hogikyan ND; Wodchis WP; Spak C; Kileny PR
J Voice; 2001 Dec; 15(4):576-86. PubMed ID: 11792036
[TBL] [Abstract][Full Text] [Related]
38. [Botulinum toxin. A new therapeutic alternative in spastic dysphonia (laryngeal abductor dystonia)].
Loven JO; Brøndbo K; Ganes T
Tidsskr Nor Laegeforen; 1993 Mar; 113(7):841-3. PubMed ID: 8480289
[TBL] [Abstract][Full Text] [Related]
39. Effects of botulinum toxin type A injections on aerodynamic measures of spasmodic dysphonia.
Adams SG; Durkin LC; Irish JC; Wong DL; Hunt EJ
Laryngoscope; 1996 Mar; 106(3 Pt 1):296-300. PubMed ID: 8614192
[TBL] [Abstract][Full Text] [Related]
40. Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: acoustic, aerodynamic, and videoendoscopic findings.
Zwirner P; Murry T; Swenson M; Woodson GE
Laryngoscope; 1992 Apr; 102(4):400-6. PubMed ID: 1556889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]